The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Observational study of treatment patterns among patients initiating first-line treatment for chronic lymphocytic leukemia in the U.S. community oncology setting.
Matthew J. Monberg
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Arthur C. Houts
No relevant relationships to disclose
Mark S. Walker
No relevant relationships to disclose
Gaetano Bonifacio
Employment or Leadership Position - GlaxoSmithKline